Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (6)

« Back to Publications

EQ-5D vision bolt-on in macular degeneration: associations with visual measures and effect on utility differences and cost-effectiveness of stereotactic radiotherapy.

Zhu X. et al, (2026), Health Qual Life Outcomes, 24

Content validity, face validity and comprehensiveness of generic quality-of-life measures in adults and children with rare genetic conditions and their carers: a think aloud qualitative study.

Bourke M. et al, (2026), Qual Life Res, 35

Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).

Jackson TL. et al, (2026), BMJ, 393

Stereotactic radiotherapy for nAMD: areas for improvement - Authors' reply.

Jackson TL. et al, (2025), Lancet, 406, 26 - 27

Reduction in inpatient and severe condition visits for respiratory diseases during the COVID-19 pandemic in Wuhan, China

Zhu X. et al, (2024), Global Transitions

The stability of physicians' risk attitudes across time and domains.

Zhu X. et al, (2023), Soc Sci Med, 339